Redwood Wealth Management Group, LLC Amylyx Pharmaceuticals, Inc. Transaction History
Redwood Wealth Management Group, LLC
- $133 Billion
- Q2 2024
A detailed history of Redwood Wealth Management Group, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Redwood Wealth Management Group, LLC holds 200 shares of AMLX stock, worth $574. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$574% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMLX
# of Institutions
140Shares Held
44.6MCall Options Held
226KPut Options Held
909K-
Vanguard Group Inc Valley Forge, PA4.22MShares$12.1 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.34MShares$9.59 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$7.66 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$7.49 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.9MShares$5.46 Million1.57% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $168M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...